These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 857295)

  • 1. In vitro detection of cell-mediated immunity to antigens associated with Hodgkin's granulomas.
    Andersen E
    Scand J Haematol; 1977 Apr; 18(4):343-7. PubMed ID: 857295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity to Hodgkin's splenic tissue measured by leucocyte migration inhibition.
    Hancock BW; Bruce L; Richmond J
    Br Med J; 1976 Mar; 1(6009):556-7. PubMed ID: 1260271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lawrence transfer factor and Hodgkin's disease.
    Smith RA; Ezdinli E; Bigley NJ; Han T
    Lancet; 1973 Feb; 1(7800):434. PubMed ID: 4119754
    [No Abstract]   [Full Text] [Related]  

  • 4. Ferritin, a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma.
    Hancock BW; Bruce L; May K; Richmond J
    Br J Haematol; 1979 Oct; 43(2):223-33. PubMed ID: 116671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity in Hodgkin's disease.
    Advani SH; D'Silva H; Gothoskar BP; Dinshaw KA; Nair CN; Gopalkrishna R; Talwalkar GV; Desai PB
    Cancer; 1979 Feb; 43(2):492-9. PubMed ID: 421176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.
    Gangal SG; Gothoskar BP; Joshi CS; Advani SH
    Br J Cancer; 1976 Mar; 33(3):267-72. PubMed ID: 1063589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of host defence against infection during chemotherapy of Hodgkin's disease.
    Addison I; Babbage J; Gandossini M; Souhami R
    Cancer Chemother Pharmacol; 1978; 1(3):129-33. PubMed ID: 312166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte-migration test in sarcoidosis.
    Becker FW; Krull P; Deicher H; Kalden JR
    Lancet; 1972 Jan; 1(7742):120-3. PubMed ID: 4108983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of cell mediated immunity in Hodgkin's disease (apropos of 30 cases)].
    Laurens A; Morin A; Aubry J; Laurent G; Audreu G; Hainaut J
    Ann Med Interne (Paris); 1975 Dec; 126(12):829-36. PubMed ID: 1225093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of the cellular immunity tests during the evolution of Hodgkin's disease.
    Răileanu-Moţoiu I; Dumitrescu A; Costescu M; Mocanu N; Berceanu S
    Med Interne; 1983; 21(3):203-15. PubMed ID: 6665494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
    Chan SH; Wallen WC; Levine PH; Periman P; Perlin E
    Int J Cancer; 1977 Mar; 19(3):356-63. PubMed ID: 191408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity in Hodgkin's disease: status after 5 years' remission.
    Hancock BW; Bruce L; Whitham MD; Dunsmore IR; Ward AM; Richmond J
    Br J Cancer; 1982 Oct; 46(4):593-600. PubMed ID: 7138765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological monitoring during chemotherapy for advanced Hodgkin's disease.
    Alexopoulos CG; Wiltshaw E
    Cancer; 1978 Dec; 42(6):2631-40. PubMed ID: 310334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of splenectomy, radiotherapy and chemotherapy on the immune response in Hodgkin's disease.
    Van Rijswijk RE; Sybesma JP; Kuipers JT; Zegers BJ; Borst-Eilers E
    Neth J Med; 1976; 19(4-5):201-8. PubMed ID: 980188
    [No Abstract]   [Full Text] [Related]  

  • 17. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed hypersensitivity and lymphocytic transformation in patients with Hodgkin's disease and granulomas.
    Pick AI; Duer D; Kessler H; Kenan Z; Weiss H; Topilski M
    Cancer; 1978 Jun; 41(6):2192-6. PubMed ID: 657087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucocyte migration inhibition and leucocyte adherence inhibition studies, using ferritin as 'antigen', in patients with malignant lymphoma.
    Bruce L; Grail A; Hancock BW
    Hematol Oncol; 1984; 2(2):169-77. PubMed ID: 6745868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.